Text Size
Trial record 4 of 16 for:    Atrial Fibrillation | Open Studies | NIH, U.S. Fed
Previous Study | Return to List | Next Study

The Dynamics of Human Atrial Fibrillation

This study is currently recruiting participants.
Verified January 2013 by University of California, San Diego
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Sanjiv Narayan, MD, PhD, University of California, San Diego
ClinicalTrials.gov Identifier:
NCT01008722
First received: November 5, 2009
Last updated: January 15, 2013
Last verified: January 2013
History of Changes
  Purpose

The study is conducted in patients with atrial fibrillation undergoing clinically prescribed ablation. The study hypothesis is that ablation at specific sites that are identified to 'drive' the atrial fibrillation may improve the success of the ablation procedure.


Condition
Atrial Fibrillation
Atrial Tachyarrhythmia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Dynamics of Human Atrial Fibrillation

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of California, San Diego:

Primary Outcome Measures:
  • Survival Free of Atrial Fibrillation [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Termination of atrial fibrillation during ablation [ Time Frame: acute ] [ Designated as safety issue: No ]

Estimated Enrollment: 98
Study Start Date: June 2009
Estimated Study Completion Date: November 2013
Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   21 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Subjects will be men and women of all races aged 21 to 80 years undergoing clinically indicated ablation of Atrial Fibrillation.

Criteria

Inclusion Criteria:

  • Subjects will be patients undergoing electrophysiology study and ablation for paroxysmal or persistent atrial fibrillation (AF) after having failed >or= 1 anti-arrhythmic drug.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01008722

Contacts
Contact: Sanjiv M. Narayan, MD, PhD (858) 642-1108 snarayan@ucsd.edu
Contact: Kathleen C. Mills, BA (858) 552-8585 ext 2250 kcmills@ucsd.edu

Locations
United States, California
University of California, San Diego Active, not recruiting
La Jolla, California, United States, 92093
VA San Diego Medical Center Recruiting
San Diego, California, United States, 92161
Contact: Sanjiv M. Narayan, MD, PhD     858-642-1108     snarayan@ucsd.edu    
Contact: Kathleen C. Mills, BA     (858) 552-8585 ext 2250     kcmills@ucsd.edu    
Principal Investigator: Sanjiv M. Narayan, MD, PhD            
Sponsors and Collaborators
University of California, San Diego
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Principal Investigator: Sanjiv M. Narayan, MD, PhD University of California, San Diego
  More Information

No publications provided by University of California, San Diego

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Sanjiv Narayan, MD, PhD, Professor of Medicine, University of California, San Diego
ClinicalTrials.gov Identifier: NCT01008722     History of Changes
Other Study ID Numbers: 684, R01HL083359
Study First Received: November 5, 2009
Last Updated: January 15, 2013
Health Authority: United States: Federal Government

Keywords provided by University of California, San Diego:
Atrial Fibrillation
Ablation

Additional relevant MeSH terms:
Atrial Fibrillation
Tachycardia
Arrhythmias, Cardiac
 Heart Diseases
Cardiovascular Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on May 19, 2013